Back
Seres Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
2
MCRB
Seres Therapeutics, Inc.
Last Price:
$8.77
Seasonality Move:
-13.01%
7 Day Trial
ALL ACCESS PASS
$
7
Seres Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Seres Therapeutics, Inc. has on average historically risen by 27.9% based on the past 10 years of stock performance.
-
Seres Therapeutics, Inc. has risen higher in 1 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 10%
-
Is Seres Therapeutics, Inc. Stock Undervalued?The current Seres Therapeutics, Inc. [MCRB] share price is $8.74. The Score for MCRB is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
-
MCRB is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
Will Seres Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Seres Therapeutics, Inc. has on average historically risen by 27.9% based on the past 10 years of stock performance.
Seres Therapeutics, Inc. Stock Rating
Sell
2
Seres Therapeutics, Inc. (MCRB)
is a Sell
Is Seres Therapeutics, Inc. overpriced?
-
Seres Therapeutics, Inc. has risen higher in 1 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 10%
Seres Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
serestherapeutics.com
52-Week Data
52-Week High:
29.98
52-Week Low:
6.53
Prediction Charts
Market Cap:
76.5M
Price in USD:
8.74
Volume:
63.1K
Beta:
2.08
Technical Analysis
SMA50:
14.64
SMA100:
16.38
SMA200:
14.54
52-Wk Change:
-47.34%
Stock Predictions
-
Is Seres Therapeutics, Inc. stock public?Yes, Seres Therapeutics, Inc. is a publicly traded company.
-
What is the Seres Therapeutics, Inc. stock quote today?The Seres Therapeutics, Inc. stock price is 8.74 USD today.
-
How to buy Seres Therapeutics, Inc. stock online?You can buy Seres Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-30 | 15.05 | 14.92 | 15.16 | 14.41 |
| Feb-2 | 15.06 | 15.15 | 16.12 | 14.84 |
| Feb-3 | 15.54 | 15.40 | 15.54 | 14.88 |
| Feb-4 | 14.92 | 13.63 | 15.23 | 12.99 |
| Feb-5 | 14.02 | 13.40 | 14.31 | 13.20 |
| Feb-6 | 13.50 | 13.96 | 14.32 | 13.50 |
| Feb-9 | 14.00 | 14.63 | 14.69 | 13.78 |
| Feb-10 | 14.55 | 14.31 | 14.65 | 14.06 |
| Feb-11 | 14.49 | 14.09 | 14.49 | 13.59 |
| Feb-12 | 10.04 | 8.22 | 10.96 | 8.00 |
| Feb-13 | 8.81 | 8.47 | 9.97 | 8.38 |
| Feb-17 | 8.47 | 8.28 | 8.65 | 7.85 |
| Feb-18 | 8.17 | 8.23 | 9.37 | 7.95 |
| Feb-19 | 8.23 | 8.74 | 8.74 | 7.89 |
Seres Therapeutics, Inc. Earnings
Seres Therapeutics, Inc. Earnings Report: Per Share Seres Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Seres Therapeutics, Inc. Forecast Revenue Growth
Seres Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Seres Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $4.48 per share, a decrease next quarter of $0.00 per share, a decrease this year of $8.74 per share, and a decrease next year of $0.91 per share.
* Seres Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.